Resources

WHO: Target product profile for Lassa virus vaccine

This resource is an outline of the WHO target product profile development  for Lassa, as well as a generic description of WHO's Vaccine Pre-qualification process.

Read more

WHO: 1996 - Lassa fever in Sierra Leone - update 2

The conclusion of the WHO support mission is that a major epidemic of Lassa Fever has occurred in Kailahun and Kenema Districts and is continuing as unusually large numbers of severely ill patients are still being admitted to hospital, with a large number of deaths still occurring.

Read more

Emerging disease or emerging diagnosis?: Lassa fever and Ebola in Sierra Leone

This article looks beyond Ebola in 2014 to the history of efforts to control VHFs in the Mano River and challenges the idea that there was a vacuum of knowledge. Highlighted instead are politics of knowledge which have run through global health and which have prioritized particular forms of knowledge and ways of dealing with disease. Ethnographic research on the emergence of Lassa and the subsequent emergence of Ebola in West Africa is presented, focusing on the development of technologies and institutions to detect and manage both viruses.

Read more

Lassa fever

In a study of Lassa fever in Sierra Leone, West Africa, this paper identifies two variables associated with a high risk of death, and evaluates the efficacy of ribavirin and Lassa virus–convalescent plasma for the treatment of Lassa fever.

Read more